Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Poster Presentations

Pituitary and Neuroendocrinology 2

Previous section
Interdisciplinary Endocrinology 1
Table of contents
Next section
Thyroid 2

ea0063p672 | Pituitary and Neuroendocrinology 2

The management of acromegaly: experience of the endocrinology

ea0063p673 | Pituitary and Neuroendocrinology 2

Sheehan’s syndrome: case report

ea0063p674 | Pituitary and Neuroendocrinology 2

First and second day cortisol levels as predictors of long-term hypocortisolism after pituitary surgery

ea0063p675 | Pituitary and Neuroendocrinology 2

Preoperative predictors of Cushing’s disease remission after transsphenoidal endoscopic surgery

ea0063p676 | Pituitary and Neuroendocrinology 2

An unexpected intrasellar meningioma in a patient with anosmia

ea0063p677 | Pituitary and Neuroendocrinology 2

Erectile dysfunction in diabetic men revealing an empty sella (n=3)

ea0063p678 | Pituitary and Neuroendocrinology 2

Case report of pituitary adenoma with subclinical Cushing’s disease

ea0063p679 | Pituitary and Neuroendocrinology 2

Giant empty sella and pituitary insufficiency 20 years after raditherapy for nasopharyngeal cancer

ea0063p680 | Pituitary and Neuroendocrinology 2

Acromegaly complications at the time of diagnosis

ea0063p681 | Pituitary and Neuroendocrinology 2

First case of mature teratoma and yolk sac testis tumor associated to inherited MEN-1 syndrome: a case report

ea0063p682 | Pituitary and Neuroendocrinology 2

Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study

ea0063p683 | Pituitary and Neuroendocrinology 2

GHD children’s stature evolution after one year of treatment with growth hormone

ea0063p684 | Pituitary and Neuroendocrinology 2

Effects of growth hormone deficiency (ghd) and gh treatment on early markers of atherosclerosis in children

ea0063p685 | Pituitary and Neuroendocrinology 2

Copeptin in differential diagnosis in polyuric states

ea0063p686 | Pituitary and Neuroendocrinology 2

Delayed psychotic episod in a patient with panhipopituitarism and central diabetes insipidus after craniopharyngioma removal

ea0063p687 | Pituitary and Neuroendocrinology 2

Patient compliance, mainly due to lower socioeconomic status, is the principal predictor of effective acromegaly treatment: data from a single tertiary center

ea0063p688 | Pituitary and Neuroendocrinology 2

Case of Pituitary corticotropinoma - from PCOS to obvious Cushing’s

ea0063p689 | Pituitary and Neuroendocrinology 2

Macroprolactinoma in apoplexy associated to 23 year-old Down’s syndrome

ea0063p690 | Pituitary and Neuroendocrinology 2

Radiologic and laboratory predictors for the surgical outcome in acromegaly

ea0063p691 | Pituitary and Neuroendocrinology 2

Acquired bilateral cortical adrenal atrophy in a middle-aged male

ea0063p692 | Pituitary and Neuroendocrinology 2

Osteoporosis with Multiple Vertebral Fractures in a 61-year-old Male Revealing a Cushing Disease

ea0063p693 | Pituitary and Neuroendocrinology 2

Ectopic neurohypophysis: an unusual cause of growth hormone deficiency

ea0063p694 | Pituitary and Neuroendocrinology 2

New markers of systemic inflammation and oxidative macromolecular damage in partial and total Adult Growth Hormone Deficiency

ea0063p695 | Pituitary and Neuroendocrinology 2

Severe salt wasting syndrome due to spontaneous epidural haematoma

ea0063p696 | Pituitary and Neuroendocrinology 2

Endoscopic transsphenoidal surgery for Cushing’s disease; a single surgeon experience

ea0063p697 | Pituitary and Neuroendocrinology 2

Therapeutic alternatives for acth secreting aggressive pituitary adenoma–case report

ea0063p698 | Pituitary and Neuroendocrinology 2

New diagnosis of Kallmann syndrome in an adult Fugitive

ea0063p699 | Pituitary and Neuroendocrinology 2

Hypogonadotropic hypogonadism in a male patient with glycogen storage disease type 1A

ea0063p700 | Pituitary and Neuroendocrinology 2

Severe hyponatremia caused by secondary adrenal insufficiency in a patient with central diabetes insipidus: A case report

ea0063p701 | Pituitary and Neuroendocrinology 2

Acromegaly in a 29-year-old woman: restored fertility after surgery and radiosurgery

ea0063p702 | Pituitary and Neuroendocrinology 2

Cardiovascular and metabolic comorbidities in patients with Cushing’s disease at diagnosis and after long term remission

ea0063p703 | Pituitary and Neuroendocrinology 2

Change of the response to cabergoline after pregnancy in a patient with partially resistant microprolactinoma

ea0063p704 | Pituitary and Neuroendocrinology 2

Sex differences in presentation but not in outcome for ACTH-dependent Cushing’s syndrome

ea0063p705 | Pituitary and Neuroendocrinology 2

Adrenal crisis in treated patients with Cushing’s syndrome

ea0063p706 | Pituitary and Neuroendocrinology 2

Visualisation characteristic of the inactive pituitary adenoma (IPA)

ea0063p707 | Pituitary and Neuroendocrinology 2

A case of isolated adrenocorticotropic hormone deficiency diagnosed with ventricular fibrillation by prolonged QT interval

ea0063p708 | Pituitary and Neuroendocrinology 2

Hypophysitis secondary to anti-pd1/pd-l1 blockade: variations in presentation, four distinct cases

ea0063p709 | Pituitary and Neuroendocrinology 2

Protein expression of convertases involved in POMC processing in silent and functioning corticotroph tumors

ea0063p710 | Pituitary and Neuroendocrinology 2

Lymphocytic hypophysitis with disturbance of both anterior and posterior pituitary function preceded by headache, diagnosed as meningitis

ea0063p711 | Pituitary and Neuroendocrinology 2

Whole genome demethylation status of somatic DNA extracted from different pituitary adenoma types

ea0063p712 | Pituitary and Neuroendocrinology 2

Does silent pituitary neuroendocrine tumors show lower specific adenohypophyseal gene hormone expression than functioning ones?

ea0063p713 | Pituitary and Neuroendocrinology 2

Characterizing the microenvironment of pituitary neuroendocrine tumours, new approaches and tools to explore the function and contribution of folliculostellate cells

ea0063p714 | Pituitary and Neuroendocrinology 2

Low arginine vasopressin levels in patients with central diabetes insipidus is not associated with anaemia

ea0063p715 | Pituitary and Neuroendocrinology 2

Silent somatotroph tumors

ea0063p716 | Pituitary and Neuroendocrinology 2

Giant prolactinoma: a case with thirty-five years of follow-up

ea0063p717 | Pituitary and Neuroendocrinology 2

Glycogenosis and hypofisis pathology, importance of a multidisciplinary management

ea0063p718 | Pituitary and Neuroendocrinology 2

A rare case of a TSH/GH secreting pituitary macroadenoma

ea0063p719 | Pituitary and Neuroendocrinology 2

Control of hyperglycemia in a young male patient with gigantism during transition: a case report

ea0063p720 | Pituitary and Neuroendocrinology 2

Central diabetes insipidus revealing Langerhans cell histiocytosis

ea0063p721 | Pituitary and Neuroendocrinology 2

Endocrine manifestations during Langerhans cell histiocytosis

ea0063p722 | Pituitary and Neuroendocrinology 2

Growth hormone therapy in Noonan syndrome

ea0063p723 | Pituitary and Neuroendocrinology 2

Elevated Chromogranin A levels in a patient with acromegaly – who is the culprit?

ea0063p724 | Pituitary and Neuroendocrinology 2

The influence of acromegaly treatment on subclinical left ventricular dysfunction assessed by two-dimensional speckle tracking echocardiography (2D-STE)-preliminary results

ea0063p725 | Pituitary and Neuroendocrinology 2

Remission rate of acromegaly after somatostatin analogs withdrawal: an update

ea0063p726 | Pituitary and Neuroendocrinology 2

Detection of pituitary adenoma specific circulating tumour DNA using semiconductor sequencing

ea0063p727 | Pituitary and Neuroendocrinology 2

Is idiopathic mild hyperprolactinemia a cardiovascular risk factor?

ea0063p728 | Pituitary and Neuroendocrinology 2

Acromegaly in McCune-Albright Syndrome: case report

ea0063p729 | Pituitary and Neuroendocrinology 2

Muscle dysfunction is associated with poor quality of life in patients with Cushing’s syndrome long-term after remission

ea0063p730 | Pituitary and Neuroendocrinology 2

Trial-in-progress: A multicenter, dose-titration, open-label phase 2b study of nevanimibe hydrochloride, A novel ACAT1 inhibitor, for the treatment of classic congenital adrenal hyperplasia

ea0063p731 | Pituitary and Neuroendocrinology 2

Therapeutic decisions in acromegaly according to disease control in patients with acromegaly with or without prior treatment: data from baseline analysis of the SAGIT® validation study

ea0063p732 | Pituitary and Neuroendocrinology 2

Assessing clinical meaningfulness of quality of life (qol) change in patients with Cushing’s disease: calculation of minimal important difference estimates for the cushingqol using anchor and distribution-based approaches

ea0063p733 | Pituitary and Neuroendocrinology 2

Moderate hyponatremia at discharge is associated with increased risk of recurrence in patients with community-acquired pneumonia

ea0063p734 | Pituitary and Neuroendocrinology 2

A phase 2 study assessing osilodrostat in children and adolescent patients with Cushing’s disease – Rationale and methods

ea0063p735 | Pituitary and Neuroendocrinology 2

The changing face of cushing disease in the 21st century: mood disorders and body image perception

ea0063p736 | Pituitary and Neuroendocrinology 2

Prevalence of silent acromegaly in prolactinomas (PASP): an Italian experience

ea0063p737 | Pituitary and Neuroendocrinology 2

A multicentre, randomized, open-label, Phase IV study investigating management of pasireotide-associated hyperglycaemia with incretin-based therapy or insulin in patients with acromegaly or Cushing’s disease (CD)

ea0063p738 | Pituitary and Neuroendocrinology 2

Hemangiopericytoma mimicking a pituitary adenoma: a case report

ea0063p739 | Pituitary and Neuroendocrinology 2

Investigation of the role of miR-126-3p in pituitary insufficiency following traumatic brain injury

ea0063p740 | Pituitary and Neuroendocrinology 2

Secretory and proliferative activity of GH-secreting pituitary adenoma

ea0063p741 | Pituitary and Neuroendocrinology 2

Ongoing challenges in treatment of cushing’s disease due to pituitary macroadenoma

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more